Title
discovery of CDX-6512, a gastrointestinal-stable methionine-gamma-lyase as a potential orally-administered enzyme therapy for homocystinuria
Conference Dates
May 22 – 27, 2022
Abstract
Please click Additional Files below to see the full abstract.
Recommended Citation
Leann Teadt, "discovery of CDX-6512, a gastrointestinal-stable methionine-gamma-lyase as a potential orally-administered enzyme therapy for homocystinuria" in "Enzyme Engineering XXVI", Andy Bommarius, Georgia Institute of Technology, USA; Vesna Mitchell, Codexis, USA; Doug Fuerst, GSK, USA Eds, ECI Symposium Series, (2022). https://dc.engconfintl.org/enzyme_xxvi/1
Poster 22.pdf (84 kB)
COinS